Epiminder
Epiminder is focused on transforming epilepsy management through its innovative Minder system, the first FDA-authorised implantable continuous EEG monitoring (iCEM) system. This technology provides continuous, long-term EEG monitoring, offering enhanced treatment planning and remote care capabilities for patients with drug-resistant epilepsy. Epiminder aims to improve the quality of life for epilepsy patients by providing actionable information regarding seizures and other EEG events.
Short position
Epiminder (ASX:EPI) has 0.01% of its shares on issue reported as short positions as of 21 Sept 2026, or about 19,014 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. EPI is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Epiminder (EPI) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $2.1MM (source: ASX (Markit))vs $445.2KM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 29 Sep 2026
- NPAT
- −$42.7Mvs −$34.5M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- −$0.28vs −$0.20 (FY25)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- +378.9%FY
- EPS YoY
- n/aTTM
- ASX (Markit)
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- −187.6%
- Operating margin
- −2,047.1%
- Net margin
- −2,004.4%
- FCF margin
- n/a
- ROE
- −45.2%
- ROA
- −38.6%
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- 9.7×
- Interest cover
- −35.8×
- Cash dividends paid / net profit
- n/a
- Market cap
- $63.9M
- P/E
- n/a
- P/B
- 0.8×
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: Yahoo Finance and ASX (Markit), as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $2.1MM (source: ASX (Markit)) | $445.2KM (source: ASX (Markit)) | $6.6MM (source: ASX (Markit)) | $5.5MM (source: ASX (Markit)) |
| Gross profit | −$4.0M | n/a | n/a | n/a |
| Operating income | −$43.6M | −$28.6M | −$21.1M | −$20.6M |
| Interest expense | $1.2M | $3.0M | $2.0M | $1.0M |
| Pretax income | −$42.7M | −$34.5M | −$22.4M | −$21.3M |
| Tax | $0 | $0 | $0 | $0 |
| NPAT | −$42.7M | −$34.5M | −$22.4M | −$21.3M |
| Net interest income | $912.0K | −$3.0M | −$2.0M | −$1.0M |
| EPS basic | −$0.28 | −$0.20 | −$0.13 | −$0.12 |
| EPS diluted | −$0.28 | −$0.20 | −$0.13 | −$0.12 |
| Shares | 216.7M | 175.2M | 175.2M | 175.2M |
- ASX (Markit)
Financial reports
The company's own filings, newest first
- FY26 Appendix 4E and Annual ReportAnnual Results26 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Apr 2026via asx_announcements
- 1HFY26 Appendix 4D and Financial ReportHalf Year Results25 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Jan 2026via asx_announcements
- Remuneration and Nomination Committee CharterFinancial Reportvia crawler
- Audit and Risk Committee CharterFinancial Reportvia crawler
- Continuous Disclosure PolicyFinancial Reportvia crawler
- Securities Trading PolicyFinancial Reportvia crawler
- Anti-Bribery and Corruption PolicyFinancial Reportvia crawler
Showing 10 of 15 reports